Long-Term Outcomes of Kidney Transplantation Across a Positive Complement-Dependent Cytotoxicity Crossmatch

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Transplantation

• Publication date

  2014-06-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.TP.0000442782.98131.7cPMID 24854670
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Complement-binding anti-HLA antibodies and kidney-allograft survival.

  2013cited by this paper
• Skin Cancer in Organ Transplant Recipients — Where Do We Stand Today ?

  2013cited by this paper
• Five‐Year Outcomes in Living Donor Kidney Transplants With a Positive Crossmatch

  2013cited by this paper
• Effect of high‐dose intravenous immunoglobulin on anti‐HLA antibodies in sensitized kidney transplant candidates

  2012cited by this paper
• Infusion of High-Dose Intravenous Immunoglobulin Fails to Lower the Strength of Human Leukocyte Antigen Antibodies in Highly Sensitized Patients

  2012influential reference
• Terminal Complement Inhibition Decreases Antibody‐Mediated Rejection in Sensitized Renal Transplant Recipients

  2011cited by this paper
• Desensitization protocols and their outcome.

  2011influential reference
• Desensitization in HLA-incompatible kidney recipients and survival.

  2011cited by this paper
• De Novo Anti‐HLA Antibody After Pandemic H1N1 and Seasonal Influenza Immunization in Kidney Transplant Recipients

  2011cited by this paper
• The Impact of Proteasome Inhibition on Alloantibody-Producing Plasma Cells In Vivo

  2011cited by this paper
• Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation

  2010cited by this paper
• Sensitized renal transplant recipients: current protocols and future directions

  2010cited by this paper
• Baseline Donor‐Specific Antibody Levels and Outcomes in Positive Crossmatch Kidney Transplantation

  2010cited by this paper
• Living Donor Kidney Transplantation Across Positive Crossmatch: The University of Illinois at Chicago Experience

  2009cited by this paper
• Comparison of Combination Plasmapheresis/IVIg/Anti‐CD20 Versus High‐Dose IVIg in the Treatment of Antibody‐Mediated Rejection

  2009cited by this paper
• Reducing De Novo Donor‐Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss

  2009cited by this paper
• Positive Cross‐Match Living Donor Kidney Transplantation: Longer‐Term Outcomes

  2009cited by this paper
• Proteasome inhibition reduces donor-specific antibody levels.

  2009cited by this paper
• Skin Cancer in Organ Transplant Recipients—Where Do We Stand Today?

  2008cited by this paper
• Rituximab and intravenous immune globulin for desensitization during renal transplantation.

  2008cited by this paper
• Renal Transplantation in Patients With Positive Lymphocytotoxicity Crossmatches: One Center’s Experience

  2008cited by this paper
• Frontiers in nephrology: heterologous immunity, T cell cross-reactivity, and alloreactivity.

  2007cited by this paper
• Successful living donor kidney transplantation across HLA and ABO incompatibilities.

  2006cited by this paper
• A Comparison of Plasmapheresis Versus High‐Dose IVIG Desensitization in Renal Allograft Recipients with High Levels of Donor Specific Alloantibody

  2006cited by this paper
• Kidney paired donation and optimizing the use of live donor organs.

  2005cited by this paper
• A Comparison of Populations Served by Kidney Paired Donation and List Paired Donation

  2005cited by this paper
• Transplanting patients with a positive donor‐specific crossmatch: A single center's perspective

  2004cited by this paper
• ATG induction is associated with an increase in anti-HLA antibodies after kidney transplantation.

  2004cited by this paper
• Antibody‐Mediated Rejection Criteria – an Addition to the Banff ′97 Classification of Renal Allograft Rejection

  2003cited by this paper
• The Banff 97 working classification of renal allograft pathology.

  1999cited by this paper
• Significance of the positive crossmatch test in kidney transplantation.

  1969cited by this paper

• Outcomes of Kidney Transplantation in Highly HLA-Sensitized Patients Treated with Intravenous Immuno-Globulin, Plasmapheresis and Rituximab: A Meta-Analysis

  2024cites this paper
• Assessment of donor specific IgG Anti-HLA subclasses before and after kidney transplantation in Upper Egypt: A Single Center Study.

  2023cites this paper
• Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation

  2023cites this paper
• Case report: Successful simultaneous heart-kidney transplantation across a positive complement-dependent cytotoxic crossmatch

  2022cites this paper
• Low Incidence of Acute Antibody-Mediated Rejection after HLA Desensitization in Living Donor Kidney Transplant Recipients

  2022cites this paper
• HLA Antibody Incompatible Renal Transplantation: Long-term Outcomes Similar to Deceased Donor Transplantation

  2021cites this paper
• Presence of a survival benefit of HLA-incompatible living donor kidney transplantation compared to waiting or HLA-compatible deceased donor kidney transplantation with a long waiting time.

  2021cites this paper
• Kidney transplantation in highly sensitized recipients

  2021cites this paper
• Highly Sensitized Patients Are Well Served by Receiving a Compatible Organ Offer Based on Acceptable Mismatches

  2021cites this paper
• Creating Options for Difficult-to-match Kidney Transplant Candidates.

  2020cites this paper
• Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement on Heart Transplantation: Patient Eligibility, Selection, and Post-Transplantation Care.

  2020cites this paper
• Double-Filtration Plasmapheresis Plus Low-Dose Anti-thymocyte Globulin and Tacrolimus in Asian Living-Donor Kidney Transplantation With Donor-Specific Anti-HLA Antibody.

  2020cites this paper
• Desensitization in HLA Incompatible Transplantation

  2019cites this paper
• Transplant outcomes in positive complement-dependent cytotoxicity- versus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: a retrospective study

  2019cites this paper
• Effect of simultaneous presence of anti-blood group A/B and -HLA antibodies on clinical outcomes in kidney transplantation across positive crossmatch: a nationwide cohort study

  2019cites this paper
• Outcome of Desensitization Therapy in Immunologically High-Risk Kidney Transplantation: Single-Center Experience.

  2019cites this paper
• The results of HLA‐incompatible kidney transplantation according to pre‐transplant crossmatch tests: Donor‐specific antibody as a prominent predictor of acute rejection

  2019cites this paper
• Postoperative Results

  2019cites this paper
• Transplantation in highly sensitized patients: challenges and recommendations

  2018cites this paper
• Dual targeting: Combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients

  2018cites this paper
• Anti-HLA Donor-Specific IgG Subclasses and C1q-binding Evolution in Posttransplant Monitoring

  2018cites this paper
• Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti‐HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients

  2018cites this paper
• Kidney transplantation of 32 patients from HLA-incompatible live donors: Efficacy and outcome after desensitization

  2017cites this paper
• Chronic allograft injury: Mechanisms and potential treatment targets.

  2017cites this paper
• Outcome of Pretransplantation Therapeutic Plasma Exchange in Highly Sensitized Deceased-donor Kidney Transplant Recipients.

  2017cites this paper
• Changing Paradigms in the Management of Rejection in Kidney Transplantation

  2017cites this paper
• The Impact of Donor-Specific Anti-Human Leukocyte Antigen (HLA) Antibody Rebound on the Risk of Antibody Mediated Rejection in Sensitized Kidney Transplant Recipients

  2017cites this paper
• Progress in Transplantation: Will It Be Achieved in Big Steps or by Marginal Gains?

  2017cites this paper
• Optimizing Outcomes in Pediatric Renal Transplantation Through the Australian Paired Kidney Exchange Program

  2017cites this paper
• Increased risk of infection‐associated death with incompatible kidney transplantations

  2017cites this paper
• Renal Transplantation Across HLA and ABO Barriers

  2017cites this paper
• Kidney transplantation from HLA-incompatible live donors: Efficiency and outcome of 32 patients after desensitisation.

  2017cites this paper
• Increased access to transplantation of highly sensitized patients under the new kidney allocation system. A single center experience.

  2017cites this paper
• B cells in chronic antibody mediated rejection of renal transplants

  2016cites this paper
• Immunological risk assessment: The key to individualized immunosuppression after kidney transplantation.

  2016cites this paper
• Antibodies against HLA-DP recognize broadly expressed epitopes.

  2016cites this paper
• Desensitization Using Bortezomib and High-dose Immunoglobulin Increases Rate of Deceased Donor Kidney Transplantation

  2016cites this paper
• Evolution of Immunosuppressive Agents in Renal Transplantation: An Updated Review

  2016cites this paper
• Renal transplantation across the donor-specific antibody barrier: Graft outcome and cancer risk after desensitization therapy.

  2016cites this paper
• Acute and Chronic Allograft Dysfunction in Kidney Transplant Recipients.

  2016cites this paper
• Pharmacologic Targeting of Regulatory T Cells for Solid Organ Transplantation: Current and Future Prospects

  2015cites this paper
• Marginal kidneys for transplantation

  2015cites this paper
• Intravenous immunoglobulin in kidney transplantation

  2015cites this paper
• Alternative Living Kidney Donation Programs Boost Genetically Unrelated Donation

  2015cites this paper
• Erratum to: Pharmacologic Targeting of Regulatory T Cells for Solid Organ Transplantation: Current and Future Prospects

  2015cites this paper
• The 25th anniversary of the Eurotransplant Acceptable Mismatch program for highly sensitized patients.

  2015cites this paper
• Cutting Edge: CTLA-4Ig Inhibits Memory B Cell Responses and Promotes Allograft Survival in Sensitized Recipients

  2015cites this paper
• C URRENT OPINION Acute rejection in vascularized composite allotransplantation

  2014cites this paper
• Acute rejection in vascularized composite allotransplantation

  2014cites this paper